论文部分内容阅读
目的研究普米克令舒(吸入用布地奈德混悬液)联合博利康尼(特布他林)氧气雾化吸入治疗小儿毛细支气管炎的临床效果。方法 120例毛细支气管炎患儿为研究对象,将其随机分为观察组与对照组,各60例。对照组给予常规治疗(地塞米松磷酸钠静脉滴注),观察组给予普米克令舒联合博利康尼氧气雾化吸入治疗,比较两组治疗效果。结果观察组总有效率显著高于对照组,差异有统计学意义(P<0.05);且观察组咳喘消失时间、湿啰音消失时间、住院时间均少于对照组,差异有统计学意义(P<0.05)。结论普米克令舒联合博利康尼氧气雾化吸入治疗小儿毛细支气管炎的临床效果理想,值得在临床上进一步推广。
Objective To study the clinical effect of pulmicort respules (inhalation of budesonide suspension) and bleomycin (terbutaline) aerosol inhalation on children with bronchiolitis. Methods A total of 120 children with bronchiolitis were randomly divided into observation group and control group, 60 cases in each group. The control group was given routine treatment (dexamethasone sodium phosphate intravenous infusion), the observation group was treated with Pulmicort respules combiblocconazole oxygen inhalation therapy, the treatment effect was compared between the two groups. Results The total effective rate in the observation group was significantly higher than that in the control group (P <0.05), and the disappearance time of cough and asthma, disappearance time of wet rales and hospital stay in the observation group were all less than those in the control group (P <0.05). Conclusions Pulmicort respules combiblipanib aerosol inhalation for the treatment of children with bronchiolitis is an ideal clinical result, which is worth further promotion in clinic.